The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...

Parkinson’s disease is a progressive neurodegenerative disease that ... Non-motor symptoms in PD can affect many areas like mood, sleep, and pain and may be more challenging than movement issues, ...

DELRAY BEACH, Fla. — Delray Medical Center in Florida cut the ribbon on its newest high-tech machine last week that targets brain areas to treat movement disorders such as essential tremor and ...

Scientists are unraveling the mystery of what triggers Huntington’s disease, a devastating and fatal hereditary disorder that strikes ... leads to problems with movement, thinking and behavior.

Scientists are unraveling the mystery of what triggers Huntington’s disease, a devastating and fatal hereditary disorder that strikes ... leads to problems with movement, thinking and behavior.

(McLean Hospital’s Harvard Brain Tissue Resource Center/NIH NeuroBioBank via AP) Scientists are unraveling the mystery of what triggers Huntington’s disease, a devastating and fatal hereditary ...

In 2015, the Youth Risk Behavior Survey (YRBS) run by the Centers for Disease Control ... graduate medical training programs offered elective rotations for eating disorders, and just 8% offered ...

Parkinson's disease (PD) is the second most common neurodegenerative disorder, primarily characterized by motor dysfunction. Its pathological hallmark is the abnormal aggregation of α-synuclein ...